Free Trial
→ If Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret? (From Colonial Metals) (Ad) Buy VKTX Stock  Free VKTX Stock Alerts

Viking Therapeutics (VKTX) SEC Filings & 10K Form

Viking Therapeutics logo
$24.57 +2.35 (+10.58%)
As of 04:00 PM Eastern
Compare

Recent Viking Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/08/2025
6:05 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4/A
04/08/2025
4:23 PM		Viking Therapeutics (Filer)
Form DEFA14A
04/08/2025
4:25 PM		Viking Therapeutics (Filer)
Form ARS
04/02/2025
5:29 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:05 AM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
3:32 PM		Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/06/2025
7:15 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:16 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:11 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:12 PM		FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:13 PM		Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:13 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:14 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:14 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:32 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:25 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:16 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
5:22 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
5:13 PM		MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
12:54 PM		VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
11/04/2024
5:31 AM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
8:48 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:37 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
6:27 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
6:28 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:10 PM		Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:00 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2024
3:09 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
11:26 AM		STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
09/20/2024
8:20 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:21 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:29 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
6:23 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
6:23 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:11 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:13 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:00 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
6:47 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
7:03 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:38 PM		SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
3:05 PM		Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
New “Trump” currency proposed in DC (Ad)

A former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, now!” Jim Rickards is one of the most connected men in Washington.

We’ve posted the full recording online, where you can view it free of charge, here.
07/31/2024
3:05 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:05 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
4:55 PM		Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
4:56 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
4:58 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2024
4:00 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
3:10 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
6:10 AM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
6:46 PM		Viking Therapeutics (Filer)
Form S-8 POS
05/22/2024
6:54 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:33 PM		Viking Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/03/2024
7:51 PM		Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
3:04 PM		Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
8:27 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
3:02 PM		Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/24/2024
7:42 PM		Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
3:05 PM		Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VKTX) was last updated on 4/14/2025 by MarketBeat.com Staff
From Our Partners
The biggest story CNBC isn't talking about (yet)
This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...
Stansberry Research | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
If Gold Is ‘Stalling,’ Why Are Banks Hoarding Billions In Secret?
Prosperity was something every American family could build, protect, and pass down. Because that's what legacy...
Colonial Metals | Sponsored
BITCOIN
Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....
Awesomely, LLC | Sponsored
Elon Musk is helping print “new gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...
American Alternative | Sponsored
DeFi Coin on Verge of Breakout!
Crypto’s down — but the fundamentals aren’t. Strategic investors are using this dip to scoop up undervalued...
Crypto 101 Media | Sponsored